Muscles (Mar 2024)

An Intronic Heterozygous <i>SYNE2</i> Splice Site Mutation: A Rare Cause for Myalgia and hyperCKemia?

  • Theresa Paulus,
  • Natalie Young,
  • Emily Jessop,
  • Carolin Berwanger,
  • Christoph Stephan Clemen,
  • Rolf Schröder,
  • Rafal Ploski,
  • Christian Hagel,
  • Yorck Hellenbroich,
  • Andreas Moser,
  • Iakowos Karakesisoglou

DOI
https://doi.org/10.3390/muscles3010010
Journal volume & issue
Vol. 3, no. 1
pp. 100 – 109

Abstract

Read online

SYNE2 mutations have been associated with skeletal and cardiac muscle diseases, including Emery-Dreifuss muscular dystrophy (EDMD). Here, we present a 70-year-old male patient with muscle pain and elevated serum creatine kinase levels in whom whole-exome sequencing revealed a novel heterozygous SYNE2 splice site mutation (NM_182914.3:c.15306+2T>G). This mutation is likely to result in the loss of the donor splice site in intron 82. While a diagnostic muscle biopsy showed unspecific myopathological findings, immunofluorescence analyses of skeletal muscle and dermal cells derived from the patient showed nuclear shape alterations when compared to control cells. In addition, a significantly reduced nesprin-2 giant protein localisation to the nuclear envelope was observed in patient-derived dermal fibroblasts. Our findings imply that the novel heterozygous SYNE2 mutation results in a monoallelic splicing defect of nesprin-2, thereby leading to a rare cause of myalgia and hyperCKemia.

Keywords